Lir Life Sciences Corp. is a listed company. Its directors and officers file their transactions with SEDI. 5 insiders have disclosed 17 filings since 18 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 2,130 companies) published 12 filings over the same period, against 17 filings here.
Insider buying of Lir Life Sciences Corp. has been absent for the past year. Filings reach the SEDI feed a median of 1 day after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
· cache
17 of 17 declarations
Lir Life Sciences Corp. is a company focused on developing innovative solutions in the life sciences sector. It is listed on the Toronto Stock Exchange under the symbol XTSE.